Aspira Pathlab & Diagnostics Ltd Share Price

Diagnostic Services

BSE: 540788 Small Cap ISIN: INE500C01017

As on 24 January 2025 at 06:40 IST

₹79.29

+ 1.55

(1.99%)

Sell Buy

Over 1 Month

29.56%

Over 6 Months

155.77%

Over 1 Year

120.56%

Over 3 Years

-12.14%

Aspira Pathlab & Diagnostics Ltd Summary

Close ₹ 79.29

Open ₹ 77.74

High ₹ 79.29

Low ₹ 77.74

Volume 2,137

Net Turnover (in ₹) ₹ 1,69,208

52Wk High ₹ 83.93

52Wk Low ₹ 25

52Wk High / Low

83.93

Aspira Pathlab & Diagnostics Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 81.61

EPS (TTM) -

Book Value (BV) 10.80

Div. Yield -

P/E (TTM) -304.96

Price/Book Value 7.34

Delivery % 100 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 6.11

EV to Sales 2.44

PEG Ratio -

ROA -20.01

ROE -

Debt-Equity 0.16

Net Profit Margin -20.23

Operating Profit Margin -5.76

Aspira Pathlab & Diagnostics Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

No data available

Balance Sheet

No data available

Cash Flow

No data available

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	13.63	14.78	19.64	15.41	8.70
Total Expenses	16.30	14.87	15.18	14.03	12.92
Profit Before Tax	-2.67	-0.09	4.46	1.38	-4.21
Profit After Tax	-2.67	-0.09	4.46	1.38	-4.24
Operating Profit after Depreciation	-2.30	0.33	4.83	2.27	-3.20

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	6.79	8.01	9.57	7.75	8.70
Total Non Current Assets	10.35	11.49	10.99	7.90	11.05
Total Current Assets	4.36	5.86	7.14	3.88	3.29
TOTAL ASSETS	14.71	17.34	18.14	11.78	14.34
Total Shareholder's Fund	10.14	12.75	12.79	8.31	3.80

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	1.05	-0.01	2.03	5.67	-1.87
Net Cash used in Investing Activities	0.14	0.16	-0.51	-0.09	0.24
Net Cash used in Financing Activities	-0.95	-0.94	-1.35	-2.17	1.27

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-06
Total Revenue	6.18	4.64	3.82	2.60
Total Expenses	4.90	4.37	4.02	3.03
Profit Before Tax	1	0.04	-0.50	-0.72
Profit After Tax	0.99	0.05	-0.50	-0.72
Operating Profit after Depreciation	1.36	0.42	-0.12	-0.33

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	6.18	4.64	3.82	3.46	3.32
Total Expenses	4.82	4.28	3.93	3.84	3.69
Profit Before Tax	1	-0.01	-0.49	-0.75	-0.72
Profit After Tax	0.99	-0.02	-0.50	-0.74	-0.71
Operating Profit after Depreciation	1.44	0.45	-0.03	-0.28	-0.23

Aspira Pathlab & Diagnostics Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 76.99

S2 76.23

S3 74.73

Pivot 78.49

R1 79.25

R2 80.75

R3 81.51

Moving Average

20 SMA 71.32

50 SMA 69.30

100 SMA 56.63

200 SMA 43.75

Aspira Pathlab & Diagnostics Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 10 Sep 2022

AGM 10/09/2022 49th Annual General Meeting scheduled to be held on September 10, 2022 Book Closure for 49th Annual General Meeting of the Company (As Per BSE Announcement Dated on 13/08/2022) Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Notice convening the 49th Annual General Meeting of the Company, scheduled to be held on Saturday, September 10, 2022 at 11:30 A.M. through Video Conferencing/ Other Audio Visual Means. (As Per BSE Announcement Dated on 18.08.2022) Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we enclose a summary of proceedings of the 49th Annual General Meeting of the Company held on Saturday, September 10, 2022 through Video Conferencing (VC). The meeting was commenced at 11:30 A.M. and concluded at 11:50 A.M. Kindly take the above information on your record. (As Per BSE Announcement Dated on 10.09.2022) We wish to inform you that the 49th Annual General Meeting of Aspira Pathlab & Diagnostics Limited held on Saturday, September 10, 2022 at 11:30 A.M. through Video Conference in compliance with the provisions of Companies Act, 2013 & circulars issued by Ministry of Corporate Affairs in this behalf. In this regard, please find enclosed the following: a) Scrutinizer''s Report dated September 12, 2022 pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014. b) Voting results of remote e-voting and e-voting during AGM, pursuant to regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on your records. Aspira Pathlab & Diagnostics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 12.09.2022)

AGM Date: 26 Sep 2023

AGM 26/09/2023 Newspaper advertisement regarding Fifty Annual General Meeting of Aspira Pathlab & Diagnostics Limited to be held on Tuesday September 26, 2023 at 12.00 PM (IST) via VC/OVAM. (As Per BSE Announcement Dated on 01/09/2023) Proceedings of 50th Annual General Meeting of the Company held on Tuesday, September 26 2023 (As per BSE Announcement Dated on 26/09/2023) Appointment of Mr. Manas Mengar (DIN:10218206)as the Non-Executive and Independent Director of the Company for the period of five consecutive years. (As Per BSE Announcement Dated on 27.09.2023)

AGM Date: 27 Sep 2024

AGM 27/09/2024 51st Annual General Meeting to be held on Friday, September 27, 2024 at 12.00 P.M (IST) through Video Conferencing/Other Audio Visual Means. (As Per BSE Announcement dated on 24.08.2024) Summary Proceedings of 51st Annual General Meeting of the Company. (As Per BSE Announcement Dated on 27.09.2024)

Aspira Pathlab & Diagnostics Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Aspira Pathlab & Diagnostics Ltd	₹79.29	₹81.61
Max Healthcare Institute Ltd	₹1,082.95	₹1,05,277.04
Apollo Hospitals Enterprise Ltd	₹6,922.45	₹99,534.21
Fortis Healthcare Ltd	₹635.75	₹47,996.46
Syngene International Ltd	₹847.25	₹34,104.95
Global Health Ltd	₹1,070.50	₹28,752.28

Aspira Pathlab & Diagnostics Ltd News

Aspira Pathlab & Diagnostics schedules board meeting

On 12 November 2024

30 Oct 2024, 04:55 pm

Aspira Pathlab & Diagnostics AGM scheduled

On 27 September 2024

28 Aug 2024, 12:02 pm

Aspira Pathlab & Diagnostics to announce Quarterly Result

On 13 August 2024

05 Aug 2024, 02:32 pm

Aspira Pathlab & Diagnostics to conduct board meeting

On 28 May 2024

21 May 2024, 12:07 pm

Aspira Pathlab & Diagnostics revises board meeting date

To a later date

06 Feb 2024, 12:39 pm

Aspira Pathlab & Diagnostics Ltd Stock Analysis

Annual revenue for Aspira Pathlab & Diagnostics Ltd decreased by 7.79% to ₹13.63 crore in FY 2024 from ₹14.78 crore in FY 2023.
Annual Net Profit for Aspira Pathlab & Diagnostics Ltd increased by 2912.63% to ₹-2.67 crore in FY 2024 from ₹-0.09 crore in FY 2023.
Promoter Shareholding in Aspira Pathlab & Diagnostics Ltd remains unchanged by 0.00% in the most recent quarter, from 18.55% in September 2024 to 18.55% in December 2024.
Aspira Pathlab & Diagnostics Ltd delivered a 1-year return of 120.56% compared to the Nifty 50, which provided a return of 0% as of the last trading session.
Aspira Pathlab & Diagnostics Ltd share price moved up by 1.99% from its previous close of INR ₹77.74. The latest Aspira Pathlab & Diagnostics Ltd share price is INR ₹79.29.
Aspira Pathlab & Diagnostics Ltd share price today has been at a low of 77.74 and a high of 79.29. Over the past 52 weeks, the Aspira Pathlab & Diagnostics Ltd share price has seen a low of 25 and a high of 83.93.